ATICH

ATICH

Antifibrinolytic Therapy in acute IntraCerebral Haemorrhage. A pilot study testing the safety and feasibility of administering aminocaproic acid within 3 hours of intracerebral haemorrhage and maintaining therapeutic levels for 24 hours. The goal was to enroll 20 patients; trial was halted after 3 patients were enrolled.